Extended-spectrum β-lactamase (ESBL)-producing Salmonella are one of the most important public health problems in developed countries. ESBL-producing Salmonella strains have been isolated from humans in Asian countries neighboring Japan, along with strains harboring the plasmid-mediated extended-spectrum cephalosporin (ESC)-resistance gene, ampC (pAmpC). However, only a few studies have investigated the prevalence of ESC-resistant Salmonella in chicken products in Japan, which are the main vehicle of Salmonella transmission. The aim of this study was to investigate the prevalence of ESBL-producing, pAmpC-harboring, or carbapenem-resistant Salmonella in chicken products in Japan. In total, 355 out of 779 (45.6%) chicken product samples collected from 1996–2010 contained Salmonella, resulting in 378 distinct isolates. Of these isolates, 373 were tested for resistance to ESCs, cephamycins, or carbapenems. Isolates that showed resistance to one or more of these antimicrobials were then examined by PCR and DNA sequence analysis for the presence of the blaCMY, blaCTX-M, blaTEM, and blaSHV resistance genes. Thirty-five resistant isolates were detected, including 26 isolates that contained pAmpC (blaCMY-2), and nine ESBL-producing isolates harboring blaCTX-M (n = 4, consisting of two blaCTX-M-2 and two blaCTX-M-15 genes), blaTEM (n = 4, consisting of one blaTEM-20 and three blaTEM-52 genes), and blaSHV (n = 1, blaSHV-12). All pAmpC-harboring and ESBL-producing Salmonella isolates were obtained from samples collected after 2005, and the percentage of resistant isolates increased significantly from 0% in 2004 to 27.9% in 2010 (P for trend = 0.006). This increase was caused in part by an increase in the number of Salmonella enterica subsp. enterica serovar Infantis strains harboring an approximately 280-kb plasmid containing blaCMY-2 in proximity to ISEcp1. The dissemination of ESC-resistant Salmonella containing plasmid-mediated blaCMY-2 in chicken products indicates the need for the development of continuous monitoring strategies in the interests of public health.
Citation: Noda T, Murakami K, Etoh Y, Okamoto F, Yatsuyanagi J, Sera N, et al. (2015) Increase in Resistance to Extended-Spectrum Cephalosporins in Salmonella Isolated from Retail Chicken Products in Japan. PLoS ONE 10(2): e0116927. https://doi.org/10.1371/journal.pone.0116927
Academic Editor: Dongsheng Zhou, Beijing Institute of Microbiology and Epidemiology, CHINA
Received: August 8, 2014; Accepted: December 17, 2014; Published: February 2, 2015
Copyright: © 2015 Noda et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: The DDBJ accession numbers for the blaCMY regions are AB750370–AB750375, AB750378–AB750380, AB750382, AB750385, AB750386, AB751211, AB751213, AB751215, AB751218, AB751219, AB751221, AB751223, AB751225, AB751227, AB751229, AB751230, AB751232, AB751234, and AB751237. The DDBJ accession numbers for blaCTX-M are AB751238, AB751240, AB751242, and AB751244. The DDBJ accession numbers for blaTEM are AB751201, AB751202, AB751205–AB751207, and AB751210. The DDBJ accession number for blaSHV is AB758624. The blaCMY-2 upstream and downstream region sequences (from isolates 1993, 2127, 2150, and 2179) are submitted under numbers AB915634, AB916358, AB906452, and LC008131, respectively.
Funding: This work was supported by the Japan Society for the Promotion of Sciences KAKENHI, Grant No. 24590846 and the Daido Life Welfare Foundation, Osaka, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Salmonella infection remains a significant public health concern worldwide. In many countries, the incidence of human infections caused by extended-spectrum cephalosporin (ESC)-resistant Salmonella has increased dramatically [1,2]. ESCs are administrated to treat salmonellosis caused by fluoroquinolone-resistant Salmonella, or in children and infants [3,4]. However, ESC-resistance genes such as blaCTX-M, blaTEM, and blaSHV, which contribute to extended-spectrum β-lactamase (ESBL) production, have been detected in Salmonella isolated from humans in Asian countries neighboring Japan [5,6]. Some of these isolates also contain plasmid-mediated ampC (pAmpC), another ESC-resistance gene . In Japan, ESC-resistant Salmonella containing pAmpC or ESBL genes, such as blaCTX-M-14 and blaCTX-M-15, have been isolated from humans [8,9].
ESC-resistant Salmonella have also been isolated from food-producing animals and their products in many countries [10,11]. Reports from Japan over the last decade show that these isolates are especially prevalent in chickens . Moreover, ESBL genes such as blaCMY, blaCTX-M, blaTEM, and blaSHV have been detected in Salmonella from food-producing-animal products in other Asian countries, and throughout the rest of the world [11,13]. In Japan, however, only a few studies have investigated the prevalence of ESC-resistant Salmonella in chicken products [14,15].
Because of the public health importance of these resistant salmonellae, it is imperative to determine their prevalence in chicken products in Japan. Therefore, the aim of this study was to investigate the prevalence of β-lactam antibiotic (cephalosporins or carbapenems) resistance in Salmonella from chicken products in Japan using molecular detection of ESBL genes and pAmpC.
Materials and Methods
Isolates and sampling
A total of 779 chicken product samples were collected, consisting of chicken meat (n = 683), giblets (n = 72), and processed chicken (tataki, thin slices of raw chicken with a minimally seared surface, n = 24). Of these samples, 622 samples originated from Japanese farms, and animals were slaughtered in Japan, 145 samples were from unrecorded origins, and 12 samples came from animals reared and slaughtered outside of Japan (11 samples were imported from Brazil, and one sample was from an unrecorded origin). All samples apart from two (described below) were collected in Fukuoka Prefecture, Japan, from 1996–2010. A total of 554 of the 779 samples were randomly collected from 282 retail outlets, including supermarkets and butcher shops, by Fukuoka prefectural food hygiene inspectors. A further 225 samples were randomly collected from 42 retail outlets by the authors from 2008–2010. Two of the 225 samples were collected in 2008 from two retail outlets in Nagasaki Prefecture, which neighbors Fukuoka Prefecture, while the remaining 223 samples were collected from 40 retail outlets in Fukuoka Prefecture, Japan.
The bacterial isolation method used for samples collected from 1996–1998 has been reported previously . Isolations carried out from 1999–2010 were conducted in accordance with the method for isolating bacteria from meat samples described in our previous report , except for 85 samples collected in 2008. Salmonella isolation was carried out from these 85 samples using a previously described method  with a minor modification, as follows: Rappaport-Vassiliadis enrichment broth (Oxoid Ltd., Hampshire, UK) was used for the isolations, along with mannitol, lysine, crystal violet, brilliant green agar (Oxoid Ltd.) and Rimler-Shotts-Maeda agar (Kanto Chemical Co., Tokyo, Japan). The overall incidence of Salmonella isolation from the samples was 45.6% (355/779) (Table 1), with isolation rates of 45.5% (311/683), 54.2% (39/72), and 20.8% (5/24) from the chicken meat, giblets, and processed chicken samples, respectively. All salmonellae were isolated at the Fukuoka Institute of Health and Environmental Sciences, except for 52 isolates that were obtained from Nakamura Gakuen University Junior College in Fukuoka Prefecture. All the isolates were serotyped using somatic antisera and flagella antisera (Denka Seiken Co., Tokyo, Japan), as previously described .
A total of 378 distinct Salmonella isolates were collected from 355 of the 779 chicken product samples. Twenty-one and one samples yielded two and three distinct isolates, respectively (Table 1). Of the 378 Salmonella isolates, 186 (49.2%) were isolated over the first 12 years (1996–2007), while the remaining 192 (50.8%) isolates consisted of 81 (21.4%), 50 (13.2%), and 61 (16.1%) isolates collected in 2008, 2009, and 2010, respectively. Of the 378 isolates, 373 (from 350 samples) were examined in the following assays (Table 1). The remaining five isolates were not tested because of damage incurred during the storage process. The tested isolates were obtained from chicken meat (n = 310), giblets (n = 35), and processed chicken (n = 5) that had been collected from 195 different outlets. The susceptibility-tested Salmonella isolates constituted 16 serovars, along with 28 untypeable strains. The dominant serovars were Salmonella enterica subsp. enterica serovar (S.) Infantis (n = 180), S. Schwarzengrund (n = 70), and S. Manhattan (n = 52) (Table 1). The incidences of Salmonella from the samples collected from 1996 to 1997, and those from 85 samples collected in 2008, have been reported previously [16,18].
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed using the disk diffusion method according to the Clinical and Laboratory Standards Institute (CLSI) guidelines [19,20]. The following 11 antimicrobials were used: cefpodoxime (10 μg), cefotaxime (30 μg), ceftazidime (30 μg), cefepime (30 μg), cefoxitin (30 μg), cefmetazole (30 μg), cefotetan (30 μg), moxalactam (30 μg), imipenem (10 μg), meropenem (10 μg), and panipenem (10 μg). Disks containing these antimicrobials were purchased from Becton Dickinson (Franklin Lakes, NJ). Escherichia coli ATCC 25922 was used as a quality control strain in accordance with CLSI guidelines [19,20]. Klebsiella pneumoniae ATCC 700603 and E. coli ATCC 35218 were used as reference strains. We used the CLSI criteria for resistance breakpoints for further resistance gene detection analyses , except for panipenem, which we defined in this study (23 mm in diameter). Isolates that were resistant to one or more of these antimicrobials were then examined by PCR to determine the presence of β-lactamase genes (blaCMY, blaCTX-M, blaTEM, and blaSHV), as previously described (Table 2) [22–25]. The resistant isolates with a zone diameter less than or equal to the breakpoints for cefpodoxime, cefotaxime, ceftazidime, or cefepime were also examined to identify ESBL production, using the phenotypic confirmatory test  with cefotaxime (30 μg)-clavulanic acid (Becton Dickinson), ceftazidime (30 μg)-clavulanic acid (Becton Dickinson), and cefpodoxime (10 μg)-clavulanic acid (10 μg) (Nissui Pharmaceutical Co., Tokyo, Japan) disks.
DNA sequence analysis of resistance genes
Nucleotide sequences of the resistance genes were determined using the DNA sequencing primers listed in Table 2 [26,27]. PCR products were purified using Microcon filters (Millipore Corporation, Bedford, MA) and were sequenced using a BigDye Terminator Cycle Sequencing Reaction v. 3.1 kit (Applied Biosystems, Carlsbad, CA) on a 3500 Genetic Analyzer (Applied Biosystems). The complementary sense and antisense sequences were aligned using the SeqManII program within the Lasergene software package (DNASTAR, Madison, WI). The DNA sequences and deduced amino acid sequences were examined using the BLAST program at the DNA Data Bank of Japan (DDBJ) , and the “β-Lactamase Classification and Amino Acid Sequences for TEM, SHV, and OXA Extended-Spectrum and Inhibitor Resistant Enzymes” website .
Pulsed-field gel electrophoresis and large plasmid profile analysis
S. Infantis isolates (n = 26), S. Manhattan isolates (n = 7), and one O-untypeable:r:1,5 isolate that were shown to carry resistance genes (blaCMY, blaTEM, blaCTX-M, and/or blaSHV) were further examined using pulsed-field gel electrophoresis (PFGE) profiling and large-plasmid profile (LPP) analysis. To compare isolates with and without resistance genes, S. Infantis isolates (n = 18) and S. Manhattan isolates (n = 18) showing susceptibility to 11 antimicrobials were also examined. Two, three, five, four, and four susceptible S. Infantis isolates were collected in 2006, 2007, 2008, 2009, and 2010, respectively. Of the 18 susceptible S. Manhattan isolates, two, one, two, three, two, two, three, and three were collected in 2003, 2004, 2005, 2006, 2007, 2008, 2009, and 2010, respectively. PFGE using BlnI restriction digestion was conducted as previously described . Similarity and cluster analyses were performed using the Dice coefficients of similarity and an unweighted pair group method with average linkage, respectively, using FPQuest Software (Bio-Rad Laboratories, Hercules, CA). For LPP analysis, total DNA was treated with 2 U/ml of S1 nuclease (incubated at 37°C for 45 min), followed by PFGE separation .
Detection of ISEcp1 and other genes related to blaCMY-2
Genetic variation in the regions upstream and downstream of blaCMY-2 was identified by restriction fragment length polymorphism (RFLP) and sequence analysis. Twenty-five blaCMY-2-harboring isolates (23 S. Infantis, one S. Manhattan, and one O-untypeable:r:1,5) were tested. A PCR fragment containing part of blaCMY-2 and its upstream region was generated by PCR using a forward primer located in ISEcp1 (ISEcp1-F: 5′-CTATCCGTACAAGGGAGTGT-3′)  and a reverse primer located in blaCMY (cmy-R) (Table 2). A PCR fragment containing part of the blaCMY-2 gene and its downstream region was generated with a forward primer located in blaCMY (cmy-F) (Table 2) and a reverse primer located in sugE (SugE-R: 5′- ATTGCAGGTTTGCTCGAAGT-3′). PCR was conducted using a HotStarTaq Plus Master Mix Kit (Qiagen, Hilden, Germany), and products were digested with MseI (New England BioLabs, Ipswich, MA) at 37°C for 1 h. Digested fragments were separated by electrophoresis on 1% (w/v) agarose gels at 100 V for 30 min. Additionally, the PCR products of three S. Infantis isolates harboring blaCMY-2 (isolates 1993, 2127, and 2150) and one S. Manhattan isolate harboring blaCMY-2 (isolate 2179) were sequenced as described above. These three S. Infantis isolates were chosen for sequence analysis of the ISEcp1 region because they showed the dominant PFGE profiles (PFP) and LPP characteristics.
Localization of blaCMY-2 by Southern blot analysis
To determine whether blaCMY-2 was located in the chromosome or on a plasmid, S1 nuclease (New England BioLabs) and BlnI (Takara Bio, Otsu, Japan) digestions were prepared from the total DNA of the four isolates selected for ISEcp1 analysis (harboring blaCMY-2) (S. Infantis isolates 1993, 2127, and 2150, and S. Manhattan isolate 2179), as well as two susceptible isolates (S. Infantis isolate 1737 and S. Manhattan isolates 2129) for use as blaCMY-2-negative controls. Total DNA was treated with 2 U/ml of S1 nuclease (incubated at 37°C for 45 min) or BlnI (incubated at 37°C for 16 h), followed by PFGE separation . Separated fingerprints were transferred to positively-charged Nylon membranes (Roche Applied Science, Penzberg, Germany) and hybridized with PCR-generated blaCMY-2 digoxigenin-labeled probes (Roche Diagnostics, Basel, Switzerland) using hybridization solution (Roche Diagnostics) according to the manufacturer’s instructions and a previous report .
Antimicrobial susceptibility testing, PCR and sequence analysis of bla genes, and extended-spectrum β-lactamase phenotyping
Of the 373 tested isolates, 35 isolates from 31 chicken meat and four giblet samples showed resistance to one or more antimicrobials. These 35 chicken product samples included 27 samples originating from Japanese farms and 8 samples from unrecorded origins. Testing showed that 35 (9.4%), 24 (6.4%), 19 (5.1%), 13 (3.5%), and four (1.1%) isolates were resistant to cefpodoxime, cefoxitin, cefotaxime, ceftazidime, and cefepime, respectively. No isolates were resistant to cefmetazole, cefotetan, moxalactam, imipenem, meropenem, or panipenem. All 35 resistant isolates harbored one or two of the resistance genes tested, with 26 pAmpC (blaCMY-2)-harboring isolates (24 S. Infantis, one S. Manhattan, and one O-untypeable:r:1,5) and nine ESBL-producing isolates, harboring blaCTX-M (n = 4, consisting of two blaCTX-M-2 and two blaCTX-M-15), blaTEM (n = 4, consisting of one blaTEM-20 and three blaTEM-52), and blaSHV (n = 1, blaSHV-12) (Tables 1 and 3). Two of the nine ESBL isolates harbored the non-ESBL gene blaTEM-1 as well as blaCTX-M-15.
An analysis of the most common resistance genes harbored by each of the serotypes showed that S. Infantis with blaCMY-2 (n = 24) was the most common serotype/resistance gene combination. No other combination occurred in more than two isolates (Table 1, 3). Of the 26 isolates harboring blaCMY-2, 24 showed resistance to cefoxitin and two showed intermediate sensitivity to cefoxitin (15–17 mm), based on the CLSI criteria . All 26 isolates harboring blaCMY-2 were susceptible to other cephamycins (cefmetazole, cefotetan, and moxalactam). Furthermore, six isolates harboring only blaCMY-2, which does not contribute to ESBL production, also showed ESBL phenotypes when tested with cefpodoxime-clavulanic acid (n = 5) or ceftazidime-clavulanic acid disks (n = 1).
Chicken product isolates harboring pAmpC and ESBL genes first appeared in 2005, and the percentage of resistant isolates increased significantly from 0% in 2004 to 27.9% in 2010 (P for trend = 0.006) (Table 1).
Pulsed-field gel electrophoresis and large plasmid analysis
One S. Infantis isolate that harbored blaCMY-2 could not be subtyped by PFGE, LPP, and the following assays because of losses in resistance incurred during storage. Therefore, only 26 of 27 S. Infantis isolates that harbored bla genes (23 blaCMY-2, one blaCTX-M-2, one blaTEM-20, and one blaTEM-52) and 18 S. Infantis isolates showing susceptibility to the antimicrobials were tested (Table 3), along with the O-untypeable:r:1,5 and S. Manhattan isolates. PFPs are shown in Table 3 and Fig. 1. S. Infantis (n = 44) and O-untypeable:r:1,5 isolates (n = 1) generated 16 PFPs (A–Q, except for O), and S. Manhattan (n = 25) generated two PFPs (R and S). S. Infantis isolates carrying blaCMY-2 that were isolated in 2008 (n = 5), 2009 (n = 6), and 2010 (n = 10) generated three, two, and six PFPs, respectively. PFP C was the predominant PFP (n = 12) for S. Infantis isolates amongst the 16 PFPs. All isolates displaying PFP C harbored blaCMY-2. S. Manhattan carrying blaCMY-2 (n = 1) that was isolated in 2010 generated PFP R, as did the other 23 S. Manhattan isolates.
The isolates consisted of 25 isolates harboring blaCMY-2 (23 Salmonella enterica subsp. enterica serovar Infantis, one S. Manhattan, and one O-untypeable:r:1,5), nine isolates harboring other bla genes (three S. Infantis and six S. Manhattan), and 36 isolates susceptible to 11 antibiotics (18 S. Infantis and 18 S. Manhattan). One S. Infantis isolate that harbored blaCMY-2 could not be analyzed by PFGE because of damage that occurred during storage. The letters, names, and figures in parentheses on the right of the dendrogram are PFPs, resistance genes, and sampling year of isolates, respectively. The 44 S. Infantis isolates were subtyped as: PFP A (n = 1), PFP B (n = 3), PFP C (n = 12), PFP D (n = 1), PFP E (n = 1), PFP F (n = 1), PFP G (n = 1), PFP H (n = 6), PFP I (n = 3), PFP J (n = 1), PFP K (n = 1), PFP L (n = 6), PFP M (n = 1), PFP N (n = 3), PFP P (n = 2), and Q (n = 1). The 25 S. Manhattan isolates belonged to subtypes PFP R (n = 24) and PFP S (n = 1). One O-untypeable:r:1,5 isolate was PFP E. The scale indicates the percent similarity, as determined by the Dice coefficients.
LPPs are shown in Table 3 and Fig. 2. S. Infantis (n = 44) generated four different LPPs (LPP 1-LPP 4). Forty-one out of the 44 S. Infantis isolates, including blaCMY-2-positive isolates, were classified as LPP 1. One O-untypeable:r:1,5 isolate harboring blaCMY-2 was classified as LPP 1. S. Manhattan (n = 25) generated four different LPPs (LPP 5-LPP 8). One S. Manhattan isolate carrying blaCMY-2 was classified as LPP 5.
These isolates consisted of 25 isolates harboring blaCMY-2 (23 Salmonella enterica subsp. enterica serovar Infantis, one S. Manhattan, and one O-untypeable:r:1,5), nine isolates harboring other bla genes (three S. Infantis and six S. Manhattan), and 36 isolates susceptible to 11 antibiotics (18 S. Infantis and 18 S. Manhattan). The 70 isolates generated eight large plasmid profiles (LPPs). The S. Infantis isolates generated LPPs 1 (n = 41), 2 (n = 1), 3 (n = 1), and 4 (n = 1). All S. Infantis isolates harboring bla genes showed LPP 1, except for one S. Infantis isolate carrying blaCTX-M-2 that was classified as LPP 2. All 18 susceptible S. Infantis isolates showed LPP 1, except for two isolates that were collected in 2009 and 2008 showing LPP 3 and LPP 4, respectively. One O-untypeable:r:1,5 isolate was classified as LPP 1. S. Manhattan isolates generated four different LPPs (LPP 5-LPP 8). LPPs 5, 6, 7, and 8 were found in one, 21, one, and two S. Manhattan isolate(s), respectively. S. Infantis, O-untypeable:r:1,5, and S. Manhattan are expressed as S. I, OUT, and S. M in the figure, respectively.
Confirmation of ISEcp1 and other genes related to blaCMY-2
MseI-RFLP profiles of the regions upstream and downstream of blaCMY-2 were identical in all 25 isolates harboring blaCMY-2. S. Infantis isolates 1993, 2127, and 2150, showing the dominant PFP C and LPP 1 characteristics, and S. Manhattan isolate 2179, the only S. Manhattan isolate harboring blaCMY-2, were also used for sequencing of the blaCMY-2 upstream and downstream regions and for Southern blot analysis. A 2,389-bp fragment containing the blaCMY-2 gene from the selected isolates was sequenced. Results showed that these fragments from S. Infantis and S. Manhattan were identical. The fragments contained partial ISEcp1, blaCMY-2, blc, and partial sugE genes. The ISEcp1 sequences from the four selected isolates were 100% identical to the sequence reported for pNF4565 (GenBank accession AY581207; 2,389/2,389 bp, 100%), a plasmid carrying blaCMY-2 from S. Typhimurium (isolated from a human in 1999) .
Localization of blaCMY-2 by Southern blot analysis
All the S. Infantis isolates harboring blaCMY-2 carried plasmids of approximately 280 kb, as did the blaCMY-2-negative S. Infantis isolate (isolate 1737, LPP 1) (Fig. 3). Southern blot analysis using a blaCMY-2 gene probe only produced a hybridization signal for the plasmids from the three S. Infantis isolates in which blaCMY-2 was detected by PCR (Fig. 3). As a result, these plasmids of approximately the same size were classified on the basis of the presence/absence of blaCMY-2. Southern hybridization using a blaCMY-2 gene probe with BlnI-digested genomic DNA from these isolates showed hybridization signals at approximately 54 kb in the three isolates harboring blaCMY-2.
Selected Salmonella enterica subsp. enterica serovar (S.) Infantis isolates were selected to demonstrate the plasmid location of blaCMY-2. (A) PFGE separation of S1 nuclease-digested genomic DNA from selected S. Infantis isolates, followed by Southern hybridization with a blaCMY-2 probe. Lane 1, Lambda ladder marker; lane 2, isolate 1993; lane 3, isolate 2127; lane 4, isolate 2150; and lane 5, isolate 1737, which does not harbor blaCMY-2. (B) BlnI-digested whole-genomic DNA from selected S. Infantis isolates, followed by Southern hybridization with a blaCMY-2 probe. Lane 1, Lambda ladder marker; lane 2, isolate 1993; lane 3, isolate 2127; lane 4, isolate 2150; and lane 5, isolate 1737, which does not harbor blaCMY-2.
One S. Manhattan isolate that contained blaCMY-2 showed two hybridization signals (approximately 310 kb and 60 kb) (Fig. 4). The 310-kb hybridization signal appeared to be hybridization background; however, the point was confirmed as a small peak of density using densitometric analysis (FPQuest Software, Bio-Rad Laboratories) (Fig. 4). Therefore, the S. Manhattan isolate was confirmed to harbor two blaCMY-2 genes in putative plasmids of 310-kb and 60-kb in size. No hybridization signal was observed for the blaCMY-2-negative S. Manhattan isolate. Southern blot analysis of the S. Manhattan isolate was carried out on two separate occasions, with the same result obtained each time.
(A) Pulsed-field gel electrophoresis (PFGE) separation of S1 nuclease- or BlnI-digested genomic DNA from S. Manhattan isolates, followed by Southern hybridization with a blaCMY-2 probe. Lane 1, Lambda ladder marker; lanes 2 and 4, isolate 2179, which harbors blaCMY-2; lanes 3 and 5, isolate 2129, which does not harbor blaCMY-2. Lanes 2 and 3, S1 nuclease-digested genomic DNA; lanes 4 and 5, BlnI-digested genomic DNA. (B) Densitometric curves of PFGE separation with S1 nuclease- and BlnI-digested genomic DNA from S. Manhattan isolate 2179. The arrows show hybridization signals and corresponding positions of densitometric curves. Lambda ladder marker consisted of concatemers starting at 48.5 kb.
In the present study, pAmpC (blaCMY-2)-harboring and ESBL-producing (resulting from carriage of blaCTX-M-2, blaCTX-M-15, blaTEM-20, blaTEM-52, or blaSHV-12) Salmonella were isolated from chicken product samples collected after 2005 in Japan. The incidence of Salmonella in these samples was 45.6%, showing that Salmonella contamination of chicken products is very common in this region of Japan. The percentage of resistant isolates also increased significantly from 0% in 2004 to 27.9% in 2010. This can be attributed in part to the increase in the number of S. Infantis isolates harboring blaCMY-2. We determined that the blaCMY-2 gene was located close to an ISEcp1 element in an approximately 280-kb plasmid, pAmpC, in S. Infantis. The presence of pAmpC in S. Infantis from chicken meat and giblets is a significant public health concern because S. Infantis is one of the main causes of human salmonellosis , and chicken meat is the main source of human S. Infantis infection in Japan .
Interestingly, Taiwan is often the first Asian country in which CMY-2-type β-lactamase-producing bacteria are isolated from humans. Fourteen, two, and one human Salmonella isolates harboring blaCMY-2 were isolated in Taiwan in 2000–2002, in Korea in 2002, and in Japan in 2007, respectively [1,36,37]. In the case of other Enterobacteriaceae, six, 12, and 17 human E. coli isolates harboring blaCMY-2 were isolated in Taiwan in 1999, in China in 2003–2005, and in Japan in 2007–2009, respectively [38–40]. Moreover, 32, 21, and one human K. pneumoniae isolates harboring blaCMY-2 were also isolated in Taiwan in 1999–2002 , in Korea in 2002–2003 , and in China in 2004 , respectively. The reason for this apparent first emergence of blaCMY-2-carrying isolates in Taiwan is unknown, and may just be a result of differences in monitoring and reporting protocols; however, this phenomenon warrants further enquiry considering the international circulation of livestock and their products, especially chickens.
The first Salmonella harboring blaCMY-2 were isolated from chicken meat in Japan, and were reported in the mid-2000s by Taguchi et al. . The isolation years (2004 or 2005, exact date unknown) of the Taguchi study coincided with the first year of detection (2005) of CMY-2 β-lactamase-producing Salmonella in the present study. Therefore, it could be surmised that blaCMY-2-harboring Salmonella began to appear in chicken meat in Japan from around 2004. Interestingly, Hiki et al. also reported that the incidence of blaCMY-2-containing E. coli isolated from broiler chickens in Japan increased after 2004 . CMY-2 β-lactamase-producing E. coli from chicken meat were reported in Taiwan in 2002 , but were not reported in Japan until 2006 [45,46]. The possibility of interspecies transmission of blaCMY-2 between Salmonella and other Enterobacteriaceae populations like E. coli in Japanese chicken birds cannot be denied. However, Shahada et al. reported that no interspecies transmission was detected in Japanese broilers when they compared Salmonella and E. coli isolates from Japanese chickens in 2010 and 2011 . Therefore, further research is required to determine when and where the interspecies transmission of blaCMY-2 from other Enterobacteriaceae to Salmonella is occurring.
The presence of blaCMY-2 genes on both the putative 310-kb plasmid and the 60-kb plasmid in the S. Manhattan isolate identified in this study might play a role in the relatively strong ESC-resistance of this isolate. The inhibition zone diameters for cefotaxime and ceftazidime (16 and 12 mm, respectively) for this isolate were the smallest of all 26 isolates harboring blaCMY-2 (averaged 23 mm and 18 mm, respectively). In addition, the zone diameters for cefpodoxime and cefoxitin for the S. Manhattan isolate were also amongst the smallest for the 26 isolates. Again, the presence of two copies of the blaCMY-2 gene in this isolate may contribute to this high level of resistance; however, further studies are needed to confirm the presence and structure of the putative 310-kb plasmid.
In this study, a 2,389-bp fragment surrounding blaCMY-2 was identical to a partial sequence of previously reported plasmids, including pNF4656 (S. Newport, >100 kb) , pNF1358 (S. Typhimurium, >100 kb) , pCVM29188 (S. Kentucky, 101,461 bp) , and pUMNK88 161 (E. coli, 161,081 bp) . These studies reported that the mobile element ISEcp1 in the plasmids led to acquisition of various resistance genes in addition to blaCMY-2. As S. Infantis plasmids from both the resistant and susceptible isolates (Fig. 2) were indistinguishable in size, the transfer of blaCMY-2 between these plasmids should be studied.
The present study suggests some flaws in common screening approaches for ESBL detection. We identified an isolate carrying blaTEM-20 that was only resistant to cefpodoxime and cefepime. Such a strain could escape detection by traditional ESBL tests, which use only cefotaxime and ceftazidime [1,10,50]. Furthermore, this isolate showed intermediate sensitivity (20 mm) to ceftiofur (30 μg) (data not shown), which supports previous findings by Rodriguez et al. . Therefore, routine ESBL screening may be improved by the use of cefpodoxime, cefepime, and/or ceftiofur.
In conclusion, we found that S. Infantis isolates harboring plasmid-borne blaCMY-2 were prevalent in chicken products in Japan after 2005. None of the studied isolates showed resistance to carbapenem antibiotics; however, the dissemination of ESC-resistant Salmonella containing plasmid-mediated blaCMY-2 demands the development of continuous monitoring strategies in the interests of public health.
We are grateful to Professor Yoshimura, Fukuoka Women’s University, for his invaluable advice. We thank the food hygiene inspectors of the Fukuoka prefectural government for collecting the samples, and for their advice. We also thank Dr. Hirata, Dr. Chijiwa, Mr. Kimoto, Dr. Horikawa, Ms. Uemura, Mr. Hamasaki, Dr. Ichihara, Ms. Maruta, and Dr. Takenaka of FIHES, for their advice.
Conceived and designed the experiments: TN KM JY. Performed the experiments: TN KM YE FO. Analyzed the data: TN KM TA DO SF. Contributed reagents/materials/analysis tools: TN KM NS MF TO TA SF. Wrote the paper: TN KM TA SF.
- 1. Su LH, Wu TL, Chia JH, Chu C, Kuo AJ, et al. (2005) Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan. J Antimicrob Chemother 55: 846–852. pmid:15872047
- 2. Mataseje LF, Xiao J, Kost S, Ng LK, Dore K, et al. (2009) Characterization of Canadian cefoxitin-resistant non-typhoidal Salmonella isolates, 2005–06. J Antimicrob Chemother 64: 723–730.
- 3. Nakaya H, Yasuhara A, Yoshimura K, Oshihoi Y, Izumiya H, et al. (2001) Multidrug-resistant and fluoroquinolone-resistant Salmonella enterica serotype Typhimurium definitive phage type 12 isolated from infantile diarrhea. Kansenshogaku Zasshi 75: 815–818.
- 4. Allen KJ, Poppe C (2002) Occurrence and characterization of resistance to extended-spectrum cephalosporins mediated by β-lactamase CMY-2 in Salmonella isolated from food-producing animals in Canada. Can J Vet Res 66: 137–144.
- 5. Xia S, Hendriksen RS, Xie Z, Huang L, Zhang J, et al. (2009) Molecular characterization and antimicrobial susceptibility of Salmonella isolates from infections in humans in Henan Province, China. J Clin Microbiol 47: 401–409. pmid:19073874
- 6. Hamidian M, Tajbakhsh M, Walther-Rasmussen J, Zali MR (2009) Emergence of extended-spectrum β-lactamases in clinical isolates of Salmonella enterica in Tehran, Iran. Jpn J Infect Dis 62: 368–371.
- 7. Su LH, Chen HL, Chia JH, Liu SY, Chu C, et al. (2006) Distribution of a transposon-like element carrying blaCMY-2 among Salmonella and other Enterobacteriaceae. J Antimicrob Chemother 57: 424–429. pmid:16396917
- 8. Izumiya H, Mori K, Higashide M, Tamura K, Takai N, et al. (2005) Identification of CTX-M-14 β-lactamase in a Salmonella enterica serovar Enteritidis isolate from Japan. Antimicrob Agents Chemother 49: 2568–2570. pmid:15917576
- 9. Morita M, Takai N, Terajima J, Watanabe H, Kurokawa M, et al. (2010) Plasmid-mediated resistance to cephalosporins in Salmonella enterica serovar Typhi. Antimicrob Agents Chemother 54: 3991–3992. pmid:20585124
- 10. Hasman H, Mevius D, Veldman K, Olesen I, Aarestrup FM (2005) β-Lactamases among extended-spectrum β-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The Netherlands. J Antimicrob Chemother 56: 115–121. pmid:15941775
- 11. Rodriguez I, Barownick W, Helmuth R, Mendoza MC, Rodicio MR, et al. (2009) Extended-spectrum β-lactamases and AmpC β-lactamases in ceftiofur-resistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003–07. J Antimicrob Chemother 64: 301–309.
- 12. Ishihara K, Takahashi T, Morioka A, Kojima A, Kijima M, et al. (2009) National surveillance of Salmonella enterica in food-producing animals in Japan. Acta Vet Scand 51: 35. pmid:19703311
- 13. Tamang MD, Nam HM, Kim TS, Jang GC, Jung SC, et al. (2011) Emergence of extended-spectrum β-lactamase (CTX-M-15 and CTX-M-14)-producing nontyphoid Salmonella with reduced susceptibility to ciprofloxacin among food animals and humans in Korea. J Clin Microbiol 49: 2671–2675.
- 14. Matsumoto Y, Kitazume H, Yamada M, Ishiguro Y, Muto T, et al. (2007) CTX-M-14 type β-lactamase producing Salmonella enterica serovar Enteritidis isolated from imported chicken meat. Jpn J Infect Dis 60: 236–238. pmid:17642544
- 15. Taguchi M, Seto K, Yamazaki W, Tsukamoto T, Izumiya H, et al. (2006) CMY-2 β-lactamase-producing Salmonella enterica serovar Infantis isolated from poultry in Japan. Jpn J Infect Dis 59: 144–146. pmid:16632924
- 16. Murakami K, Horikawa K, Ito T, Otsuki K (2001) Environmental survey of salmonella and comparison of genotypic character with human isolates in Western Japan. Epidemiol Infect 126: 159–171. pmid:11349965
- 17. Murakami K, Noda T, Onozuka D, Sera N (2013) Salmonella in liquid eggs and other foods in Fukuoka Prefecture, Japan. Int J Microbiol 2013: 463095. pmid:24288539
- 18. Furuta M, Oda T, Hiwaki H, Zaitsu S, Murakami K, et al. (2010) The relations of contamination levels of Campylobacter jejuni/coli, Salmonella and fecal coliforms in commercial chicken meats and guts. Jpn J Food Microbiol 27: 200–205.
- 19. Clinical and Laboratory Standards Institute (2009) Performance standards for antimicrobial disk susceptibility tests; approved standard. Document M02-A10. Wayne, PA: CLSI.
- 20. Clinical and Laboratory Standards Institute (2012) Performance standards for antimicrobial disk susceptibility tests; approved standard. Document M02-A11. Wayne, PA: CLSI.
- 21. Clinical and Laboratory Standards Institute (2014) Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement. Document M100-S24. Wayne, PA: CLSI.
- 22. Zhao S, Qaiyumi S, Friedman S, Singh R, Foley SL, et al. (2003) Characterization of Salmonella enterica serotype Newport isolated from humans and food animals. J Clin Microbiol 41: 5366–5371. pmid:14662912
- 23. Pagani L, Dell’Amico E, Migliavacca R, D’Andrea MM, Giacobone E, et al. (2003) Multiple CTX-M-type extended-spectrum β-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy. J Clin Microbiol 41: 4264–4269. pmid:12958255
- 24. Perilli M, Dell’Amico E, Segatore B, de Massis MR, Bianchi C, et al. (2002) Molecular characterization of extended-spectrum β-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J Clin Microbiol 40: 611–614. pmid:11825979
- 25. Colom K, Perez J, Alonso R, Fernandez-Aranguiz A, Larino E, et al. (2003) Simple and reliable multiplex PCR assay for detection of blaTEM, blaSHV and blaOXA-1 genes in Enterobacteriaceae. FEMS Microbiol Lett 223: 147–151. pmid:12829279
- 26. Liu JH, Wei SY, Ma JY, Zeng ZL, Lu DH, et al. (2007) Detection and characterisation of CTX-M and CMY-2 β-lactamases among Escherichia coli isolates from farm animals in Guangdong Province of China. Int J Antimicrob Agents 29: 576–581. pmid:17314033
- 27. Leinberger DM, Grimm V, Rubtsova M, Weile J, Schroppel K, et al. (2010) Integrated detection of extended-spectrum-beta-lactam resistance by DNA microarray-based genotyping of TEM, SHV, and CTX-M genes. J Clin Microbiol 48: 460–471. pmid:20007393
- 28. National Institute of Genetics (2014) DNA Data Bank of Japan http://blast.ddbj.nig.ac.jp/top-j.html. Accessed 24 October 2014.
- 29. Jacoby G (2014) ß-Lactamase Classification and Amino Acid Sequences for TEM, SHV and OXA Extended-Spectrum and Inhibitor Resistant Enzymes. http://www.lahey.org/Studies/. Accessed 19 January 2014.
- 30. Murakami K, Noda T, Maeda E, Sera N, Fujimoto S (2014) Easy washing of lysed cell plugs for bacterial typing by pulsed-field gel electrophoresis using simple equipment. Journal Microbiol Methods 101: 67–69. pmid:24739397
- 31. Sun Y, Zeng Z, Chen S, Ma J, He L, et al. (2010) High prevalence of blaCTX-M extended-spectrum β-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China. Clin Microbiol Infect 16: 1475–1481. pmid:21681998
- 32. Shahada F, Sekizuka T, Kuroda M, Kusumoto M, Ohishi D, et al. (2011) Characterization of Salmonella enterica serovar Typhimurium isolates harboring a chromosomally encoded CMY-2 β-lactamase gene located on a multidrug resistance genomic island. Antimicrob Agents Chemother 55: 4114–4121.
- 33. Giles WP, Benson AK, Olson ME, Hutkins RW, Whichard JM, et al. (2004) DNA sequence analysis of regions surrounding blaCMY-2 from multiple Salmonella plasmid backbones. Antimicrob Agents Chemother 48: 2845–2852.
- 34. Aviv G, Tsyba K, Steck N, Salmon-Divon M, Cornelius A, et al. (2014) A unique megaplasmid contributes to stress tolerance and pathogenicity of an emergent Salmonella enterica serovar Infantis strain. Environ Microbiol 16: 977–994. pmid:24320043
- 35. Noda T, Murakami K, Ishiguro Y, Asai T (2010) Chicken meat is an infection source of Salmonella serovar Infantis for humans in Japan. Foodborne Pathog Dis 7: 727–735. pmid:20141347
- 36. Yan JJ, Ko WC, Chiu CH, Tsai SH, Wu HM, et al. (2003) Emergence of ceftriaxone-resistant Salmonella isolates and rapid spread of plasmid-encoded CMY-2-like cephalosporinase, Taiwan. Emerg Infect Dis 9: 323–328. pmid:12643826
- 37. Fujita T, Komatsu M, Okada J, Katoh K (2011) Surveillance of nalidixic acid-resistant and extended-spectrum β-lactamase-producing Salmonella spp. isolated from human feces. Kansenshogaku Zasshi 85: 355–359. pmid:21861438
- 38. Yan JJ, Ko WC, Tsai SH, Wu HM, Jin YT, et al. (2000) Dissemination of CTX-M-3 and CMY-2 β-lactamases among clinical isolates of Escherichia coli in southern Taiwan. J Clin Microbiol 38: 4320–4325. pmid:11101558
- 39. Li Y, Li Q, Du Y, Jiang X, Tang J, et al. (2008) Prevalence of plasmid-mediated AmpC β-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC β-lactamase resistance in China. J Clin Microbiol 46: 1317–1321. pmid:18305137
- 40. Yamasaki K, Komatsu M, Abe N, Fukuda S, Miyamoto Y, et al. (2010) Laboratory surveillance for prospective plasmid-mediated AmpC β-lactamases in the Kinki region of Japan. J Clin Microbiol 48: 3267–3273. pmid:20610688
- 41. Yan JJ, Ko WC, Wu HM, Tsai SH, Chuang CL, et al. (2004) Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan. J Clin Microbiol 42: 5337–5340. pmid:15528737
- 42. Yum JH, Kim S, Lee H, Yong D, Lee K, et al. (2005) Emergence and wide dissemination of CTX-M-type ESBLs, and CMY-2- and DHA-1-type AmpC β-lactamases in Korean respiratory isolates of Klebsiella pneumoniae. J Korean Med Sci 20: 961–965. pmid:16361805
- 43. Hiki M, Usui M, Kojima A, Ozawa M, Ishii Y, et al. (2013) Diversity of plasmid replicons encoding the blaCMY-2 gene in broad-spectrum cephalosporin-resistant Escherichia coli from livestock animals in Japan. Foodborne Pathog Dis 10: 243–249. pmid:23489047
- 44. Yan JJ, Hong CY, Ko WC, Chen YJ, Tsai SH, et al. (2004) Dissemination of blaCMY-2 among Escherichia coli isolates from food animals, retail ground meats, and humans in southern Taiwan. Antimicrob Agents Chemother 48: 1353–1356. pmid:15047542
- 45. Hiroi M, Harada T, Kawamori F, Takahashi N, Kanda T, et al. (2011) A survey of β-lactamase-producing Escherichia coli in farm animals and raw retail meat in Shizuoka Prefecture, Japan. Jpn J Infect Dis 64: 153–155. pmid:21519132
- 46. Ahmed AM, Shimabukuro H, Shimamoto T (2009) Isolation and molecular characterization of multidrug-resistant strains of Escherichia coli and Salmonella from retail chicken meat in Japan. J Food Sci 74: M405–410. pmid:19895488
- 47. Shahada F, Chuma T, Kosugi G, Kusumoto M, Iwata T, et al. (2013) Distribution of extended-spectrum cephalosporin resistance determinants in Salmonella enterica and Escherichia coli isolated from broilers in southern Japan. Poult Sci 92: 1641–1649.
- 48. Fricke WF, McDermott PF, Mammel MK, Zhao S, Johnson TJ, et al. (2009) Antimicrobial resistance-conferring plasmids with similarity to virulence plasmids from avian pathogenic Escherichia coli strains in Salmonella enterica serovar Kentucky isolates from poultry. Appl Environ Microbiol 75: 5963–5971.
- 49. Fernandez-Alarcon C, Singer RS, Johnson TJ (2011) Comparative genomics of multidrug resistance-encoding IncA/C plasmids from commensal and pathogenic Escherichia coli from multiple animal sources. PLOS One 6: e23415. pmid:21858108
- 50. Riano I, Moreno MA, Teshager T, Saenz Y, Dominguez L, et al. (2006) Detection and characterization of extended-spectrum β-lactamases in Salmonella enterica strains of healthy food animals in Spain. J Antimicrob Chemother 58: 844–847. pmid:16935865